Nitric Acid

Nitric Acid

SCHEMBL9845192

O=[N+]([O-])O.O=[N+]([O-])c1ccc(C2CCCc3cncn32)cc1Br

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 16/20 0.57
CYP11B2 P19099 7/20 0.48
CYP11B1 P15538 3/20 0.48
KCNH2 Q12809 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitric Acid SCHEMBL9845190 1.00 CYP19A1 (0.57) CYP19A1CYP11B2CYP11B1KCNH2
SCHEMBL9845187 0.97 CYP19A1 (0.60) CYP19A1CYP11B2CYP11B1KCNH2
Nitric Acid SCHEMBL9845216 0.92 CYP19A1 (0.57) CYP19A1CYP11B2CYP11B1KCNH2
Nitric Acid SCHEMBL9845218 0.92 CYP19A1 (0.57) CYP19A1CYP11B2CYP11B1KCNH2
Nitric Acid SCHEMBL9845213 0.84 CYP19A1 (0.81) CYP19A1CYP11B2CYP11B1KCNH2
SCHEMBL9845182 0.83 CYP19A1 (0.54) CYP19A1CYP11B2CYP11B1KCNH2
Nitric Acid SCHEMBL9845214 0.83 CYP19A1 (0.59) CYP19A1CYP11B2CYP11B1KCNH2
SCHEMBL13529265 0.79 CYP19A1 (0.60) CYP19A1CYP11B2CYP11B1KCNH2
SCHEMBL7772876 0.77 CYP19A1 (0.49) CYP19A1CYP11B2CYP11B1KCNH2
SCHEMBL9866168 0.76 CYP19A1 (0.46) CYP19A1CYP11B2CYP11B1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0426225-A2 (6,7-dihydro-5H-pyrrolo[1,2-c]-imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1991-05-08 EP disclosed